Business
CSL (ASX:CSL) share price lower amid reported mRNA vaccine delays
Image source: Getty Images
The CSL Limited (ASX: CSL) share price is falling amid reports Australia might not be capable of producing mRNA vaccines until 2023.
Right now, shares in CSL are swapping hands for $276.09 – 1.33% less than yesterday’s closing price.
The fall…
Continue Reading
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News24 hours agoGirl charged with attempted murder after foster carer stabbed in Ipswich
-
General22 hours agoSharp rise in airfares push UK inflation higher in July